CUTANEOUS DRY TYPE OF SPOROTRICHOSIS IN PERSIAN CAT
Abstract
Sporotrichosis is a mycosis that infects skin and subcutaneous tissue that is chronic. This infection is caused by thermodimorphic pathogenic species of the genus Sporothrix which are distributed worldwide and are often found in tropical and subtropical regions. Transmission of sporotrichosis can occur through scratching, biting, or direct contact of injured skin with the exudate of a sick cat or directly from an environment that is contaminated either soil, plants, and decaying plant material. Sportricosis is a zoonotic disease, so it must be detected and given treatment as soon as possible so that it does not spread to other animals or to humans. A three-year-old, gray male Persian cat with a body weight of 3.2 kg was reported with a lot of dandruff all over his body. On physical examination of the skin and hair, many scales were found in all parts of the body, there was alopecia and crusts on the lateral cervical and left sides and on the dorsal side. On supporting examination using tape acetate preparation followed by cytological examination, Sporothrix spp. spores were found. The case cat was diagnosed with sporotrichosis with a fausta prognosis. Sporotrichosis in cat cases has a cutaneous clinical form with a dry lesion type. The therapy given was griseofulvin tablets 500 mg at a dose of 50 mg/kg BW administered once a day for 21 days orally, ivermectin injection (10 mg/mL) at a dose of 0.4 mg/kg BW subcutaneously. Selamectin (spot on) containing 0.75 mL (45 mg) is dripped on the nape of the neck one week after ivermectin injection, then it is recommended to cut the cat's hair short, and bathe the cat using medicated shampoo once a week. The development of the results of therapy on the 18th day of treatment showed hair growth in alopecia and crustal lesions on the lateral cervical and left and dorsal parts, but there was still scaly hair on all parts of the body, so therapy had to be extended and prescribed drugs that had higher effectiveness than the previous drug, namely itraconazole. Management of sporotrichosis requires a long period of time and routine treatment and it is necessary to carry out routine medical check-ups to determine progress.
Downloads
References
Blanco JL, Garcia ME. 2008. Immune response to fungal infection. Vet. Immunol. Immunophatol. 125: 47-70.
Duangkaew L, Chompoonek Y, Orawan L, Charles C, Chaiyan K. 2019. Cutaneous sporotrichosis in a stray cat from Thailand. Med. Mycol. Case Rep. 23: 46-49.
Frymus T, Gruffy-Jones T, Pennisi MG, Addie D, Belak S, Corine B, Herman E, Katrin G, Magaret JH, Albert L, Hans L, Fulvio M, Karin M, Alan DR, Etienne T, Uwe T, Marian CH. 2013. DERMATOPHYTOSIS IN CATS. J. Feline Med. Surg. 15: 598-604.
Garcia-Carnero LC, Martinez-Alvarez JA. 2022. Review Virulence Factors of Sporothrix schenckii. J. Fungi 8(318): 3-12.
Garcia-Carnero LC, Perez NEL, Hernandez SEG, Jose AMA. 2018. Immunity and Treatment of Sporotrichosis. J. Fungi. 4(100): 1-14.
Gonsales FF, Fernandes NCCA, Mansho W, Montenegro H, Benites NR. 2020. Direct PCR of lesions suggestive of sporotrichosis in felines. Arquivo Bras. De Med. Vet. E Zoot. 72(5): 1-5.
Govender NP, Maphanga TG, Zulu TG, Patel J, Walaza S, Jacobs C. 2015. An Outbreak of Lymphocutaneous Sporotrichosis Among Mine- Workers in South Africa. PloS Negl. Trop. Dis. 9(9): e0004096.
Han HS, Rui K. 2021. Feline sporotrichosis in Asia. Braz.J. Microbiol. 52: 125-134.
Hargis AM, Ginn PE. 2007. The Integument. Dalam McGavin MD, Zachary JF. Pathologic Basis Vet. Disease. 4th ed. St. Louis Missouri: Mosby Elsevier. Pp. 1107-1262.
Kangle S, Amladi S, Sawant S. 2006. Scaly signs in Dermatol. Indian J. Dermatol. Venereol. Leprol. 72(2): 161-164.
Lloret A, Kartin H, Maria GP, Lluis F, Diane A, Sandor B, Corine B, Herman E, Tadeusz F, Tim G, Margaret JH, Han L, Fulvio M, Karin M, Alan DR, Etienne Thiry, Uwe T, Marian CH. 2013. SPOROTRICHOSIS IN CATS: ABCD guidelines on prevention and management. J. Feline Med. and Surgery 15: 619-623.
Maharani S, Alfarisa N, Yanuartono, Soedarmanto I. 2020. Laporan Kasus: Sporotrikosis pada Kucing Persia. Indon. Med. Vet. 9(5): 860-869.
Martinez-Herrera E, Roberto A, Rigoberto H, Maria GF, Carmen R. 2021. Uncommon Clinical Presentations of Sporotrichosis: A Two-Case Report. Pathogens J. 10(1249): 1-6.
Miranda LHM, Fatima C, Leonardo PQ, Bianca PK, Sandro AP, Tania MPS. 2013. Feline sporotrichosis: Histopathological profile of cutaneous lesions and their correlation with clinical presentation. Comp. Immunol. Microbiol. Infect. Dis. 36: 425-432.
Miranda LHM, Marta AS, Tania MPS, Fernanda NM, Sandro AP, Raquel VCO, Fatima C. 2015. Severe feline sporotrichosis associated with an increased population of CD8low cells and a decrease in CD4+ cells. Med. Mycol. Adv. Access Pub. 00(00): 1-11.
Miranda LHM, Silvia JN, Isabella DFG, Menezes RC, Rodrigo A, Erica GR, Raquel VCO, Danuza SAA, Laerte F, Sandro AP. 2018. Monitoring Fungal Burden and Viability of Sporothrix spp. in Skin Lesions of Cats for Predicting Antifungal Treatment Response. J. Fungi. 4(92): 1-11.
Moriello KA, Kimberly C, Susan P, Bernard M. 2017. Diagnosis and treatment of dermatophytosis in dogs and cats. Clin. Consensus Guid. World Assoc. Vet. Dermatol. 28: 266-303.
Mueller RS, Rosenkrantz W, Bensignor E, Joanna K, Paterson T, Shiptone MA. 2020. Diagnosis and treatment of demodicosis in dogs and cats. Vet. Dermatol. 31: 4-25.
Orofino-Costa R, Rodrigues AM, Macedo PM, Bernardes-Engemann AR. 2017. Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics. Anais Bras. Dermatol. 92(5): 606-618.
Ozukum S, Reihii J, Monsang SW. 2019. Clinical management of notoedric mange (Feline scabies) in domestic cats: A case report. The Pharma Innovation J. 8(3): 306-308.
Plumb DC dan Pharm D. 2008. Plumb’s Vet. Drug Handbook Sixth Edition. Stockholm: PharmaVet Inc. Pp. 441-442, 508-510, 812.
Rabello VBS, Almeida-Silvia F, Scramignon-Costa BS, Motta BS, Macedo PM, Teixeira MM, Almeida-Paes R, Irinyi L, Meyer W, Zancope-Oliveira RM. 2022. Environmental Isolation of Sporothrix brasiliensis in an Area with Recurrent Feline Sporotrichosis Cases. Front. Cel. Infect. Microbiol.12(894297): 1-7.
Rossow JA, Flavio Q, Diego HC, Karlyn DB, Brendan RJ, Jose GP, Isabella DFG, Sandro AP. 2020. A One Health Approach to Combatting Sporothrix brasiliensis: Narrative Review of an Emerging Zoonotic Fungal Pathogen in South America. J. Fungi. 6(247): 1-26.
Schubach A, Monica BLB, Bodo W. 2008. Epidemic sporotrichosis. Cur. Opinion Infect. Dis. 21: 129-133.
Schubach TM, Armando S, Thais O, Monica BLB, Fabiano BF, Tullia C, Paulo CF, Rosani SR, Mauricio AP, Bodo W. 2004. Evaluation of an epidemic of sporotrichosis in cats: 347 cases (1998–2001). J. Am. Vet. Med. 224(10): 1623-1629.
Schubach TMP, Armando S, Thais O, Monica BLB, Figueiredo B, Cuzzi T, Sandro AP, Isabele BDS, Rodrigo DAP, Luiz RDPL, Bodo W. 2006. Canine sporotrichosis in Rio de Janeiro, Brazil: clinical presentation, laboratory diagnosis and therapeutic response in 44 cases (1998/2003). Med. Mycol. 44: 87-92.
Scott DW, Miller WH, Griffin CE. 2001. Muller & Kirk’s Small Animal Dermatol. 6th ed. Philadelphia: WB Saunders. Hlm. 336-422.
Silvia FS, Simone CSC, Vanessa AM, Juliana SL, Ana MRF. 2022. Refractory feline sporotrichosis: a comparative analysis on the clinical, histopathological, and cytopathological aspects. Braz. J. Vet. Res. 42: 1-7.
Silvia JN, Sonia RLP, Rodrigo CM, Isabella DFG, Tania MPS, Jeferson CO, Anna BFF, Sandro AP. 2015. Diagnostic accuracy assessment of cytopathological examination of feline sporotrichosis. Med. Mycol. Adv. Access Pub. 00(00): 1-5.
Souza EW, Cintia MB, Sandro AP, Isabella DFG, Ingeborg ML, Manoel MEO, Raquel VCO, Camila RC, Rosely MZ, Luisa HMM, Rodrigo CM. 2018. Clinical features, fungal load, coinfections, histological skin changes, and itraconazole treatment response of cats with sporotrichosis caused by Sporothrix brasiliensis. Sci. Rep. 8(9074): 1-10.
